Premium
RESPIRATORY DISEASE THE CURRENT TARGET FOR ANTIVIRAL THERAPY
Author(s) -
Warren Joel
Publication year - 1970
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.1970.tb53408.x
Subject(s) - medicine , measles , rubella , poliomyelitis , virology , immunology , disease , incidence (geometry) , viral hepatitis , infectious disease (medical specialty) , vaccination , physics , optics
If we accept the premise that the systemic viral exanthemata, as measles, rubella, varicella, and variola, as well as poliomyelitis, are controllable with current and future vaccines, the discussion this evening is primarily related to respiratory disease. Furthermore, if we exclude infectious hepatitis, there are few known viral diseases of significant incidence which justify energetic antiviral research.